Overview

Asia Pacific Radiation Oncology Market is poised to value over USD 2.2 billion by 2027 end at a CAGR of over 6.2% during the forecast period 2020 to 2027.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Asia Pacific Radiation Oncology Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Asia Pacific Radiation Oncology Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Asia Pacific Radiation Oncology Market:
• NTP Radioisotopes SOC Ltd.
• Varian Medical Systems
• Nordion Inc.
• Mevion Medical Systems, Inc.
• Isoray Medical
• Accuray Incorporated
• C.R. Bard, Inc.
• Ion Beam Applications (IBA)
• Elekta AB
• Curium
(Note: The list of the major players will be updated with the latest market scenario and trends)

Asia Pacific Radiation Oncology Market Segmentation:
By Type
• External Beam Radiation Therapy
   o Electron-Emitting High-Energy Linear Accelerators (Linac)
   o Compact Advanced Radiotherapy Systems
       o CyberKnife
       o Gamma Knife
       o Tomotherapy
   o Proton Therapy
   o Cyclotron
   o Synchrotron
• Internal Beam Radiation Therapy
   o Brachytherapy
      o Seeds
      o Applicators and After loaders
      o Electronic Brachytherapy
   o Systemic Beam Radiation Therapy
   o Others

By Technology  
• External Beam Radiation Therapy
 o Image-Guided Radiotherapy (IGRT)
 o Intensity Modulated Radiotherapy (IMRT)
 o Stereotactic Technology
 o Proton Beam Therapy
 o 3D Conformal Radiotherapy (3D CRT)
 o Volumetric Modulated Arc Therapy (VMAT)
• Brachytherapy
 o Low-Dose Rate Brachytherapy
 o High-Dose Rate Brachytherapy

By Application
• External Beam Radiation Therapy
 o Prostate Cancer
 o Breast Cancer
 o Lung Cancer
 o Head and Neck Cancer
 o Colorectal Cancer
 o Others
• Internal Beam Radiation Therapy
 o Prostate Cancer
 o Gynecological Cancer
 o Breast Cancer
 o Cervical Cancer
 o Penile Cancer
 o Others

By Region

• Japan
• China
• India
• Australia and New Zealand
• ASEAN
• Rest of Asia Pacific

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Asia Pacific Radiation Oncology Market By Type, By Technology, By Application and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
  1.1 Objectives of the Study
  1.2 Market Definition
  1.3 Market Scope
      1.3.1 Years Considered for the Study
      1.3.2 Market Covered
  1.4 Currency
  1.5 Limitations
  1.6 Stakeholders

2. Research Methodology
   2.1 Research Data
       2.1.1 Secondary Data
             2.1.1.1 Key Data from Secondary Sources
       2.1.2 Primary Data
             2.1.2.1 Key Data from Primary Sources
   2.2 Market Size Estimation
   2.3 Market Breakdown and Data Triangulation
   2.4 Assumptions for the Study  

3. Executive Summary
  3.1 Market Outlook
  3.2 Segment Outlook
  3.3 Competitive Insights

4. Asia Pacific Radiation Oncology Market Variables, Trends & Scope
  4.1. Market Lineage Outlook
  4.2. Penetration and Growth Prospect Mapping
  4.3. Industry Value Chain Analysis
  4.4. Cost Analysis Breakdown
  4.5. Technology Overview
  4.6. Regulatory Framework
       4.6.1. Reimbursement Framework
       4.6.2. Standards and Compliances

5. Market Overview
  5.1. Market Dynamics
       5.1.1. Market Driver Analysis
              5.1.1.1. Increasing focus of Asia Pacific Radiation Oncology Companies on Brand Protection
              5.1.1.2. Untapped Opportunities in Emerging Regions
       5.1.2. Market Restraint Analysis
              5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
       5.1.3. Industry Challenges
              5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Asia Pacific Radiation Oncology Market Analysis Tools
  6.1. Industry Analysis - Porter’s
       6.1.1. Supplier Power
       6.1.2. Buyer Power
       6.1.3. Substitution Threat
       6.1.4. Threat from New Entrants
       6.1.5. Competitive Rivalry
  6.2. Pestel Analysis
       6.2.1. Political Landscape
       6.2.2. Environmental Landscape
       6.2.3. Social Landscape
       6.2.4. Technology Landscape
       6.2.5. Legal Landscape
  6.3. Major Deals And Strategic Alliances Analysis
       6.3.1. Joint Ventures
       6.3.2. Mergers and Acquisitions
       6.3.3. Licensing and Partnership
       6.3.4. Technology Collaborations
       6.3.5. Strategic Divestments
  6.4. Market Entry Strategies
  6.5. Case Studies

7. Asia Pacific Radiation Oncology Market, By Type Historical Analysis and Forecast 2020-2027 (USD Million)
  7.1. External Beam Radiation Therapy
       7.1.1. Electron-Emitting High-Energy Linear Accelerators (Linac)
       7.1.2. Compact Advanced Radiotherapy Systems
                7.1.2.1. CyberKnife
                7.1.2.2. Gamma Knife
                7.1.2.3. Tomotherapy
       7.1.3. Proton Therapy
                7.1.3.1. Cyclotron
                7.1.3.2. Synchrotron
  7.2. Internal Beam Radiation Therapy
       7.2.1. Brachytherapy
                7.2.1.1. Seeds
                7.2.1.2. Applicators and After loaders
                7.2.1.3. Electronic Brachytherapy
       7.2.2. Systemic Beam Radiation Therapy
       7.2.3. Others

8. Asia Pacific Radiation Oncology Market, By Technology Historical Analysis and Forecast 2020-2027 (USD Million)  
  8.1. External Beam Radiation Therapy
       8.1.1. Image-Guided Radiotherapy (IGRT)
       8.1.2. Intensity Modulated Radiotherapy (IMRT)
       8.1.3. Stereotactic Technology
       8.1.4. Proton Beam Therapy
       8.1.5. 3D Conformal Radiotherapy (3D CRT)
       8.1.6. Volumetric Modulated Arc Therapy (VMAT)
  8.2. Brachytherapy
       8.2.1. Low-Dose Rate Brachytherapy
       8.2.2. High-Dose Rate Brachytherapy

9. Asia Pacific Radiation Oncology Market, By Application Historical Analysis and Forecast 2020-2027 (USD Million)  
  9.1. External Beam Radiation Therapy
       9.1.1. Prostate Cancer
       9.1.2. Breast Cancer
       9.1.3. Lung Cancer
       9.1.4. Head and Neck Cancer
       9.1.5. Colorectal Cancer
       9.1.6. Others
  9.2. Internal Beam Radiation Therapy
       9.2.1. Prostate Cancer
       9.2.2. Gynecological Cancer
       9.2.3. Breast Cancer
       9.2.4. Cervical Cancer
       9.2.5. Penile Cancer
       9.2.6. Others

10. Asia Pacific Radiation Oncology Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
   10.1. Introduction
   10.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
         10.2.1. Japan
         10.2.2. China
         10.2.3. India
         10.2.4. Australia and New Zealand
         10.2.5. ASEAN
         10.2.6. Rest of Asia Pacific
   10.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027  

11. Market Share Analysis and Competitive Landscape  

12. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
   12.1. NTP Radioisotopes SOC Ltd.
         12.1.1. Company Overview
         12.1.2. Product Portfolio
         12.1.3. SWOT Analysis
         12.1.4. Financial Overview
         12.1.5. Strategic Overview
   12.2. Varian Medical Systems
         12.2.1. Company Overview
         12.2.2. Product Portfolio
         12.2.3. SWOT Analysis
         12.2.4. Financial Overview
         12.2.5. Strategic Overview
   12.3. Nordion Inc.
         12.3.1. Company Overview
         12.3.2. Product Portfolio
         12.3.3. SWOT Analysis
         12.3.4. Financial Overview
         12.3.5. Strategic Overview
   12.4. Mevion Medical Systems, Inc.
         12.4.1. Company Overview
         12.4.2. Product Portfolio
         12.4.3. SWOT Analysis
         12.4.4. Financial Overview
         12.4.5. Strategic Overview
   12.5. Isoray Medical
         12.5.1. Company Overview
         12.5.2. Product Portfolio
         12.5.3. SWOT Analysis
         12.5.4. Financial Overview
         12.5.5. Strategic Overview          
   12.6. Accuray Incorporated
         12.6.1. Company Overview
         12.6.2. Product Portfolio
         12.6.3. SWOT Analysis
         12.6.4. Financial Overview
         12.6.5. Strategic Overview      
   12.7. C.R. Bard, Inc.
         12.7.1. Company Overview
         12.7.2. Product Portfolio
         12.7.3. SWOT Analysis
         12.7.4. Financial Overview
         12.7.5. Strategic Overview
   12.8. Ion Beam Applications (IBA)
         12.8.1. Company Overview
         12.8.2. Product Portfolio
         12.8.3. SWOT Analysis
         12.8.4. Financial Overview
         12.8.5. Strategic Overview
   12.9. Elekta AB
         12.9.1. Company Overview
         12.9.2. Product Portfolio
         12.9.3. SWOT Analysis
         12.9.4. Financial Overview
         12.9.5. Strategic Overview
   12.10. Curium
         12.10.1. Company Overview
         12.10.2. Product Portfolio
         12.10.3. SWOT Analysis
         12.10.4. Financial Overview
         12.10.5. Strategic Overview

13. Pre and Post COVID-19 Impact
   13.1. Positive influence on the healthcare industry
   13.2. The financial disruption of the manufacturing sector
   13.3. Impact of COVID-19 on emerging companies
   13.4. Significant mandates in the healthcare regulations initiated by administrations
   13.5. The overall economic slowdown of the developing and developed nations

14. FutureWise SME Key Takeaway Points for Client

Tables

Figures